Greg Cavers
Greg Cavers has made 1 open-market purchase worth $39k since Oct 2, 2026, in 1 company. The latest: $39k of HELP, filed Oct 2, 2026, scored 54 out of 100.
CFO, Helus Pharma Inc.
Follow Greg Cavers, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 2 Form 4 (opens sec.gov) |
HELPHelus Pharma Inc. · CFOCFO | New position | 54 | $39k 3,000 at $12.91 |
+0.9% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged +0.9% (100% up, 1 measured).
Questions
What stock has Greg Cavers bought?
HELP (Helus Pharma Inc.), all on the open market and reported on SEC Form 4.
When did Greg Cavers last buy?
Oct 2, 2026: 3,000 shares of HELP at $12.91, $39k in all (Form 4 (opens sec.gov)).
Has Greg Cavers filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Greg Cavers a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 2, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer